Snider Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,122
Closed -$260K 109
2025
Q3
$260K Sell
1,122
-146
-12% -$29.7K 0.07% 102
2025
Q2
$235K Buy
1,268
+97
+8% +$18K 0.07% 107
2025
Q1
$245K Sell
1,171
-77
-6% -$15K 0.08% 102
2024
Q4
$222K Buy
+1,248
New +$229K 0.07% 106

Other funds holding ABBV

Snider Financial Group's ABBV Position: Q4 2025 in Review

Snider Financial Group sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,122 shares — an estimated $260K sold.

Snider Financial Group first reported a position in ABBV in Q4 2024 and held it in 4 quarters. The position peaked at $260K in Q3 2025. 4,146 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Snider Financial Group reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • Snider Financial Group sold 1,122 AbbVie shares in Q4 2025, an estimated $260K.
  • Snider Financial Group first reported a position in AbbVie in Q4 2024 and held it in 4 quarters.
  • Snider Financial Group's AbbVie position peaked at $260K in Q3 2025.
  • 4,146 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Snider Financial Group's 13F filing for Q4 2025, filed 21 Jan 2026.